Merit Medical Systems Hits New 52-Week Low at $78.12

Merit Medical Systems, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 78.12 on October 10, 2025. This decline marks a significant point in the stock's performance, which has seen a decrease of 3.93% over the past year, contrasting sharply with the S&P 500's gain of 13.36% during the same period.
The company's market capitalization stands at USD 5,468 million, with a price-to-earnings (P/E) ratio of 42.00. Despite the recent price drop, Merit Medical maintains a strong ability to service its debt, evidenced by a healthy EBIT to interest ratio of 11.57. The company also boasts a low debt-equity ratio of 0.27, indicating a conservative approach to leverage.

In terms of profitability, Merit Medical has reported a return on equity of 8.65% and a return on capital employed (ROCE) of 9.76%. However, the stock's performance has been below par, generating a return of -15.75% over the last year, while profits have increased by 22.3%. The stock's price-to-book ratio is 3.67, suggesting it is trading at a discount compared to historical valuations of its peers.